Discovery of Novel Trypanosoma brucei Phosphodiesterase B1 Inhibitors by Virtual Screening against the Unliganded TbrPDEB1 Crystal Structure

Autor: Hermann Tenor, Albert J. Kooistra, Hengming Ke, Kristina M. Orrling, Thomas Seebeck, David S. Bailey, Chris de Graaf, Chimed Jansen, Rob Leurs, Iwan J. P. de Esch, Huanchen Wang
Přispěvatelé: Medicinal chemistry, AIMMS
Rok vydání: 2013
Předmět:
Zdroj: Journal of Medicinal Chemistry, 2013(56), 2087-2096. American Chemical Society
Jansen, C, Wang, H, Kooistra, A J, de Graaf, C, Orrling, K M, Tenor, H, Seebeck, T, de Esch, I J P, Ke, H & Leurs, R 2013, ' Discovery of novel Trypanosoma brucei phosphodiesterase B1 inhibitors by virtual screening against the unliganded TbrPDEB1 crystal structure ', Journal of Medicinal Chemistry, vol. 2013, no. 56, pp. 2087-2096 . https://doi.org/10.1021/jm3017877
ISSN: 1520-4804
0022-2623
Popis: Trypanosoma brucei cyclic nucleotide phosphodiesterase B1 (TbrPDEB1) and TbrPDEB2 have recently been validated as new therapeutic targets for human African Trypanosomiasis by both genetic and pharmacological means. In this study we report the crystal structure of the catalytic domain of the unliganded TbrPDEB1 and its use for the in silico screening for new TbrPDEB1 inhibitors with novel scaffolds. The TbrPDEB1 crystal structure shows the characteristic folds of human PDE enzymes, but also contains the parasite-specific P-pocket found in the structures of Leishmania major PDEB1 and Trypanosoma cruzi PDEC. The unliganded TbrPDEB1 X-ray structure was subjected to a structure-based in silico screening approach that combines molecular docking simulations with a protein-ligand interaction fingerprint (IFP) scoring method. This approach identified, six novel TbrPDEB1 inhibitors with IC50 values of 10–80 μM, which may be further optimized as potential selective TbrPDEB inhibitors.
Databáze: OpenAIRE